TITLE

Clinical shorts

PUB. DATE
April 2011
SOURCE
CMAJ: Canadian Medical Association Journal;4/19/2011, Vol. 183 Issue 7, p824
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on medical topics which include a study of selective serotonin reuptake inhibitors as drug treatment for generalized anxiety disorder, the role of olmesartan in the prevention or delay of microalbuminuria occurrence, and research on irbesartan in patients with atrial fibrillation.
ACCESSION #
61406272

 

Related Articles

  • Modelling of absorption, distribution and physicochemical properties of AT1 receptor antagonists / Modelovanie absorpcie, distribúcie a fyzikálnochemických vlastnosti antagonistov AT1 receptorov. Ježko, Pavol; Žufková, Viera; Remko, Milan // Acta Facultatis Pharmaceuticae Universitatis Comenianae;Dec2015, Vol. 62 Issue 2, p20 

    The theoretical chemistry methods were used to elucidate absorption, distribution and physicochemical properties of AT1 receptor antagonists and dual angiotensin II and endothelin A receptor antagonist (PS-433540). Computed partition coefficients (ALOGPS method) studied for drugs varied between...

  • New Prospects for the Drug Treatment of Generalized Anxiety Disorder - A Systematic Review. Glue, Paul; Loan, Alistair; Gale, Chris // Current Drug Therapy;May2010, Vol. 5 Issue 2, p86 

    Despite the availability of a range of treatments, a majority of patients with Generalized Anxiety Disorder (GAD) report lack of functional recovery, and newer agents are needed for this unmet therapeutic need. This is a systematic review of newer agents in development for GAD, grouped by...

  • ACE-Induced Cough Less Frequently with New AII Anatgonist.  // Kidney;Jan/Feb98, Vol. 7 Issue 1, p39 

    Investigates the incidence of cough with the angiotensin II receptor antagonist valsatran in comparison with lisinopril and hydrochlorothiazide. Rate of development of persistent cough with valsatran versus lisinopril; Differences in reduction of blood pressure and cough suppression observed...

  • Can prozac make Mr. Happy smile. Geraci, Ron; Swierczynski, Duane // Men's Health;Sep97, Vol. 12 Issue 7, p48 

    Provides information on the drug Prozac, a class of drugs called selective serotonin reuptake inhibitors used to treat everything from depression to shyness. Advantage of the side effect of Prozac for men who worry about premature ejaculation (PE); Comments of Theresa Crenshaw and James...

  • Irbesartan did not reduce cardio events in atrial fibrillation patients.  // Australian Journal of Pharmacy;Aug2011, Vol. 92 Issue 1095, p83 

    The article reports on a study which found that angiotensin-receptor blocker irbesartan did not reduce risk of cardiovascular events in atrial fibrillation patients. It references the paper "Irbesartan in patients with atrial fibrillation," by S. Yusuf and colleagues that appeared in "New...

  • Prevention of Nausea and Vomiting with Ramosetron after Total Hip Replacement. Fujii, Yoshitaka; Tanaka, Hiroyoshi // Clinical Drug Investigation;2003, Vol. 23 Issue 6, p405 

    Objective: Patients undergoing total joint replacement procedures have a remarkably high incidence of postoperative nausea and vomiting. The purpose of this study was to evaluate the efficacy and safety of ramosetron, a serotonin 5-HT[sub 3] receptor antagonist, for the prevention of nausea and...

  • Efficacy and Tolerability of Irbesartan, an Angiotensin II Receptor Antagonist, in Primary Hypertension: A Double-Blind, Placebo-Controlled, Dose-Titration Study. Guthrie, R.; Saini, R.; Herman, T.; Pleskow, W.; Sprecher, D.; Collins, G. // Clinical Drug Investigation;1998, Vol. 15 Issue 3, p217 

    This study compared the efficacy and tolerability of two dose-titrated regimens of irbesartan, an angiotensin II receptor antagonist selective for the AT subtype, vs placebo in hypertensive patients when titrated to clinical response. Patients with seated diastolic blood pressure (SeDBP) 95 to...

  • Safety of new medicines in young children. Choonara, Imti // Archives of Disease in Childhood;Sep2011, Vol. 96 Issue 9, p872 

    The author reflects on a report which highlights the safety concerns regarding the use of angiotensin II receptor blockers in preschool children. He states that new medicines can result in a significant improvement in reducing mortality and morbidity but one has to be aware that the safety...

  • Azelnidipine exerts renoprotective effects by improvement of renal microcirculation in angiotensin II infusion rats. Fujimoto, Sohachi; Satoh, Minoru; Nagasu, Hajime; Horike, Hideyuki; Sasaki, Tamaki; Kashihara, Naoki // Nephrology Dialysis Transplantation;Dec2009, Vol. 24 Issue 12, p3651 

    Background. Hypoxia-induced tubulointerstitial injury caused by loss of peritubular capillary (PTC) blood flow may be associated with progressive renal disease. Therefore, the maintenance of blood flow in PTCs may protect against loss of renal function. A long-acting calcium channel blocker,...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics